Marker Therapeutics Inc
NASDAQ:MRKR
Marker Therapeutics Inc
NASDAQ:MRKR
Price:
1.27
USD
2.42%
Market Closed
Market Cap:
$21.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Marker Therapeutics Inc
NASDAQ:MRKR
|
US |
|
T
|
Teixeira Duarte SA
F:TXC2
|
PT |
|
B
|
Burlington Stores Inc
XBER:BUI
|
US |
|
Metaplanet Inc
F:DN3
|
JP |
|
C
|
Citigroup Inc
LSE:0R01
|
US |
|
Pyxis Tankers Inc
NASDAQ:PXS
|
GR |
|
N
|
Nokia Oyj
F:NOA3
|
FI |
|
Cohort PLC
LSE:CHRT
|
UK |
|
Cimpress PLC
NASDAQ:CMPR
|
IE |
Wall St Price Targets
MRKR Price Targets Summary
Marker Therapeutics Inc
Marker Therapeutics Inc
Wall Street analysts forecast MRKR stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for MRKR is 8.02 USD with a low forecast of 5.66 USD and a high forecast of 10.5 USD.
Lowest Forecast
Price Target
5.66
USD
345% Upside
Average Forecast
Price Target
8.02
USD
532% Upside
Highest Forecast
Price Target
10.5
USD
727% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MRKR's stock price target?
Price Target
8.02
USD
8.02
USD
According to Wall Street analysts, the average 1-year price target for MRKR is 8.02 USD with a low forecast of 5.66 USD and a high forecast of 10.5 USD.
What is the Revenue forecast for Marker Therapeutics Inc?
Projected CAGR
61%
61%
The compound annual growth rate for Revenue over the next 6 years is 61%.
